Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response.
Yi-Ru PanChiao-En WuYu-Chao WangYi-Chen YehMeng-Lun LuYi-Ping HungYee ChaoDa-Wei YehChien-Hsing LinJason Chia-Hsun HsiehMing-Huang ChenChun-Nan YehPublished in: Clinical & translational immunology (2020)
This gene panel is a novel and reliable tool for predicting the response to ICIs in cancer patients and guides the appropriate administration of ICIs in clinical practice.